Recent advances in the pathophysicology of atrial fibrillation;Avances recientes en la fisiopatología de la fibrilación auricular

Archivos de Cardiologia de Mexico

Volumn 79, Issue SUPPL. 2, 2009, Pages 18-25

  Márquez, Manlio F ^a   Gómez Flores, Jorge ^a   Aranda Faustro, Alberto ^a   Cazares Campos, Iris ^a   Cárdenas, Manuel ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Atrial fibrillation; Atrial refractory period; Atrial remodeling; Maintenance; Mexico; Pathophysiology; Predisposing factors; Vagal tone

Indexed keywords

AUTONOMIC NERVOUS SYSTEM; ELECTRIC ACTIVITY; ELECTROPHYSIOLOGY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART MUSCLE CONDUCTION SYSTEM; HEART MUSCLE POTENTIAL; HEART MUSCLE REFRACTORY PERIOD; HEART RIGHT ATRIUM; HEREDITY; HUMAN; PATHOPHYSIOLOGY; REENTRY ARRHYTHMIA; REVIEW; VAGUS TONE;

ATRIAL FIBRILLATION; HUMANS;

EID: 77949363566     PISSN: 14059940     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Cárdenas M. La fibrilación auricular. PAC-EFC-1. México, Intersistemas 1998.
2. Mackenzie J. Diseases of the heart. 3a ed. 1914:211-6. Tornado de: Willius FA, Keys TE. Classics of Cardiology, Vol. 2. Nueva York, Henry Schuman Inc. 1941:769-800.
3. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96(4):1180-4.
4. Brugada R, Tapscott T, Czernuszewicz GZ, Marian AJ, Iglesias A, Mont L, et al. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997;336:905-11.
5. Chen YH, Xu SJ, Bendahhou S, Wang XL, Wang Y, Xu WY, et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003;299:251-4.
6. Darbar D, Herron KJ, Ballew JD, Jahangir A, Gersh BJ, Shen WK, et al. Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol 2003;41(12):2185-92.
7. Hong K, Piper DR, Diaz-Valdecantos A, Brugada J, Oliva A, Burashnikov E, et al. De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero. Cardiovasc Res 2005;68:433-40.
8. Brugada R. Is atrial fibrillation a genetic disease? J Cardiovasc Electrophysiol 2005;16:553-6.
9. Yamashita T, Hayami N, Ajiki K, Oikawa N, Sezaki K, Inoue M, et al. Is ACE gene polymorphism assodated with lone atrial fibrillation? Jpn Heart J 1997;38(5):637-41.
10. Lai LP, Su MJ, Yeh HM, Lin JL, Chiang FT, Hwang JJ, et al. Association of the human minK gene 38G allele with atrial fibrillation: evidence of possible genetic control on the pathogenesis of atrial fibrillation. Am Heart J 2002;144(3):485-90.
11. Bolca O, Akdemir O, Eren M, Dagdeviren B, Yildirim A, Tezel T. Left atrial maximum volume is a recurrence predictor in lone atrial fibrillation: an acoustic quantification study. Jpn Heart J 2002;43(3):241-8.
12. Efremidis M, Sideris A, Prappa E, Fillipatos G, Athanasias D, Kardara D, et al. Effect of atrial pressure increase on effective refractory period and vulnerability to atrial fibrillation in patients with lone atrial fibrillation. J Interv Card Electrophysiol 1999;3(4):307-10.
13. Reiffel JA. Is arterial stiffness a contributing factor to atrial fibrillation in patients with hypertension? A preliminary investigation. Am J Hypertens 2004;17(3):213-6.
14. Jais P, Peng JT, Shah DC, Garrigue S, Hocini M, Yamane T, et al. Left ventricular diastolic dysfunction in patients with so-called lone atrial fibrillation. J Cardiovasc Electrophysiol 2000;11(6):623-5.
15. Porthan KM, Melin JH, Kupila JT, Venho KK, Partinen MM. Prevalence of sleep apnea syndrome in lone atrial fibrillation: a case-control study. Chest 2004;125(3):879-85.
16. Sharifov OF, Fedorov W, Beloshapko GG, Glukhov AV, Yushmanova AV, Rosenshtraukh LV. Roles of adrenergic and cholinergic stimulation in spontaneous atrial fibrillation in dogs. J Am Coll Cardiol 2004;43:483-90.
17. Mansour M, Mandapati R, Berenfeld O, Chen J, Samie FH, Jalife J. Left-to-right gradient of atrial frequencies during acute atrial fibrillation in the isolated sheep heart. Circulation 2001;103:2631-6.
18. Jalife J, Berenfeld O. Molecular mechanisms and global dynamics of fibrillation: an integrative approach to the underlying basis of vortex-like reentry. J Theor Biol 2004;230:475-87.
19. Cárdenas M, González Hermosillo A. Simposio fibrilación auricular: introducción. Arch Cardiol Mex 2004;74(Supl. 2):S287-S288.
20. Cárdenas M, Urina M, Sánchez A, Gaussí C. Fibrilación auricular y Wolf-Parkinson White. Arch Inst Cardiol Mex 1967;37:38-46.
21. Hsieh MH, Tai CT, Chiang CE, Tsai CF, Chen YJ, Chan P, et al. Double atrial potentials recorded in the coronary sinus in patients with Wolff-Parkinson-White syndrome: a possible mechanism of induced atrial fibrillation. J Interv Card Electrophysiol 2004;11:97-103.
22. Goya M, Ouyang F, Ernst S, Volkmer M, Antz M, Kuck KH. Electroanatomic mapping and ablation of breakthroughs from the right atrium to the superior vena cava in patients with atrial fibrillation. Circulation 2002;106:1317-20.
23. Nanthakumar K, Lau YR, Plumb VJ, Epstein AE, Kay GN. Electrophysiological findings in adolescents with atrial fibrillation who have structurally normal hearts. Circulation 2004;110(2):117-23.
24. Todd DM, Skanes AC, Guiraudon G, Guiraudon C, Krahn AD, Yee R, Klein GJ. Role of the posterior left atrium and pulmonary veins in human lone atrial fibrillation: electrophysiological and pathological data from patients undergoing atrial fibrillation surgery. Circulation 2003;108(25):3108-14.
25. Haïssaguerre M, Jaïs P, Shah D, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-66.
26. Iturralde P, Medeiros A, Guevara M, Kershenovich S, Varela S, Colín L. Fibrilación auricular focal tratada mediante radiofrecuencia. Arch Inst Cardiol Méx 2000;70:167-72.
27. Kalifa J, Jalife J, Zaitsev AV, Bagwe S, Warren M, Moreno J, et al. Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation. Circulation 2003;108:668-71.
28. Jais P, Hocini M, Macle L, Choi KJ, Deisenhofer I, Weerasooriya R, et al. Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation. Circulation 2002;106:2479-85.
29. Takahashi Y, Iesaka Y, Takahashi A, Goya M, Kobayashi K, Fujiwara H, et al. Reentrant tachycardia in pulmonary veins of patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 2003;14:927-32.
30. Adragao P, Santos KR, Aguiar C, Neves JP, Abecassis M, Cavaco D, et al. Atrial fibrillation and effective refractory period of the pulmonary vein ostia. Rev Port Cardiol 2002;21(10):1125-34.
31. Perez-Lugones A, McMahon JT, Ratliff NB, Saliba WI, Schweikert RA, Marrouche NF, et al. Evidence of specialized conduction cells in human pulmonary veins of patients with atrial fibrillation. J Cardiovasc Electrophysiol 2003;14:803-9.
32. Tamargo J, Depón E. Nuevas terapéuticas diarias en el tratamiento de la fibrilación auricular. En: García E, Elizalde A, Onetti C, editores: Bases electrofisiológicas de las arritmias cardiacas.. Colima, Ed. Universidad de Colima 2009:54-68.
33. Weigl M, Gschwantler M, Gatterer E, Finsterer J, Stollberger C. Reflux esophagitis in the pathogenesis of paroxysmal atrial fibrillation: results of a pilot study. South Med J 2003; 96(11):1128-32.
34. Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation 2002;105(23):2753-9.
35. Smeets JL, Allessie MA, Lammers WJ, Bonke Fl, Hollen J. The wavelength of the cardiac impulse and reentrant arrhythmias in isolated rabbit atrium. The role of heart rate, autonomic transmitters, temperature, and potassium. Circ Res 1986;58:96-108.
36. Pappone C, Santinelli V, Manguso F, Vicedomini G, Gugliotta F, Augello G, et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 2004;109:327-34.
37. Jaïs P, Hocini M, Sacher F, Clémenty J, Haïssaguerre M. The place of ablation in the treatment of atrial fibrillation: where are we and where are we going?. Arch Mal Coeur Vaiss 2004;97:1071-7.
38. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96(4):1180-4.
39. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001;104(24):2886-91.
40. Sacher F, Corcuff JB, Schraub P, Le Bouffos V, Georges A, Jones SO, et al. Chronic atrial fibrillation ablation impact on endocrine and mechanical cardiac functions. Eur Heart J 2008;29:1290-5.
41. Nakamura Y, Nakamura K, Fukushima-Kusano K, Ohta K, Matsubara H, Hamuro T, et al. Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis. Thromb Res 2003;111(3):137-42.
42. Schotten U, Duytschaever M, Ausma J, Eijsbouts S, Neuberger HR, Allessie M. Electrical and contractile remodeling during the first days of atrial fibrillation go hand in hand. Circulation 2003;107:1433-9.